Chronic kidney disease (CKD) represents a major global health challenge due to its high prevalence in the general population and its substantial impact in terms of morbidity, mortality, and healthcare costs [...].
Di Lauro, M., Noce, A. (2026). Pharmaceutical Treatments for Typical CKD Comorbidities. BIOMEDICINES, 14(2), 1-3 [10.3390/biomedicines14020401].
Pharmaceutical Treatments for Typical CKD Comorbidities
Di Lauro, Manuela;Noce, Annalisa
2026-02-10
Abstract
Chronic kidney disease (CKD) represents a major global health challenge due to its high prevalence in the general population and its substantial impact in terms of morbidity, mortality, and healthcare costs [...].File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Pharmaceutical Treatments for Typical CKD Comorbidities.pdf
accesso aperto
Tipologia:
Documento in Post-print
Licenza:
Creative commons
Dimensione
139.69 kB
Formato
Adobe PDF
|
139.69 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
